LBT Innovations Limited (LBT.AX)
AUD 0.02
(N/A%)
AUD 0.02
(N/A%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | -2.91 Million AUD | 48.14% |
| 2023 | -5.62 Million AUD | 10.19% |
| 2022 | -6.26 Million AUD | -10.4% |
| 2021 | -5.67 Million AUD | -9.2% |
| 2020 | -5.19 Million AUD | -6846.75% |
| 2019 | 77 Thousand AUD | 104.99% |
| 2018 | -1.54 Million AUD | 21.53% |
| 2017 | -1.96 Million AUD | -135.28% |
| 2016 | 5.56 Million AUD | 135.28% |
| 2015 | 2.36 Million AUD | -40.69% |
| 2014 | 3.99 Million AUD | -8.02% |
| 2013 | 4.33 Million AUD | 415.32% |
| 2012 | 842 Thousand AUD | 68.4% |
| 2011 | 500 Thousand AUD | -86.76% |
| 2010 | 3.77 Million AUD | 89.56% |
| 2009 | 1.99 Million AUD | 6.64% |
| 2008 | 1.86 Million AUD | -44.96% |
| 2007 | 3.39 Million AUD | 0.0% |
| 2005 | - AUD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q4 | -1.53 Million AUD | 0.0% |
| 2024 FY | -2.91 Million AUD | 48.14% |
| 2024 Q2 | -1.37 Million AUD | 0.0% |
| 2023 Q2 | -3.46 Million AUD | 0.0% |
| 2023 Q4 | -2.16 Million AUD | 0.0% |
| 2023 FY | -5.62 Million AUD | 10.19% |
| 2022 FY | -6.26 Million AUD | -10.4% |
| 2022 Q4 | -3.23 Million AUD | 0.0% |
| 2022 Q2 | -3.03 Million AUD | 0.0% |
| 2021 Q4 | -2.91 Million AUD | 0.0% |
| 2021 FY | -5.67 Million AUD | -9.2% |
| 2021 Q2 | -2.75 Million AUD | 0.0% |
| 2020 Q2 | -2.63 Million AUD | 0.0% |
| 2020 Q4 | -2.56 Million AUD | 0.0% |
| 2020 FY | -5.19 Million AUD | -6846.75% |
| 2019 FY | 77 Thousand AUD | 104.99% |
| 2019 Q4 | -252 Thousand AUD | 0.0% |
| 2019 Q2 | 77 Thousand AUD | 0.0% |
| 2018 FY | -1.54 Million AUD | 21.53% |
| 2018 Q4 | 5.7 Million AUD | 0.0% |
| 2018 Q2 | - AUD | 0.0% |
| 2017 Q2 | 551 Thousand AUD | 0.0% |
| 2017 Q4 | -2.34 Million AUD | 0.0% |
| 2017 FY | -1.96 Million AUD | -135.28% |
| 2016 Q2 | 5.54 Million AUD | 0.0% |
| 2016 Q4 | 2.18 Million AUD | 0.0% |
| 2016 FY | 5.56 Million AUD | 135.28% |
| 2015 Q4 | 782 Thousand AUD | 0.0% |
| 2015 FY | 2.36 Million AUD | -40.69% |
| 2015 Q2 | 1.58 Million AUD | 0.0% |
| 2014 FY | 3.99 Million AUD | -8.02% |
| 2014 Q2 | 2.37 Million AUD | 0.0% |
| 2014 Q4 | 1.62 Million AUD | 0.0% |
| 2013 Q2 | 451 Thousand AUD | 0.0% |
| 2013 FY | 4.33 Million AUD | 415.32% |
| 2013 Q4 | 3.96 Million AUD | 0.0% |
| 2012 Q2 | 210.5 Thousand AUD | 68.4% |
| 2012 Q3 | 210.5 Thousand AUD | 0.0% |
| 2012 Q4 | 210.5 Thousand AUD | 0.0% |
| 2012 FY | 842 Thousand AUD | 68.4% |
| 2012 Q1 | 125 Thousand AUD | 0.0% |
| 2011 FY | 500 Thousand AUD | -86.76% |
| 2011 Q2 | 125 Thousand AUD | -85.54% |
| 2011 Q1 | 864.25 Thousand AUD | 0.0% |
| 2011 Q3 | 125 Thousand AUD | 0.0% |
| 2011 Q4 | 125 Thousand AUD | 0.0% |
| 2010 Q2 | 864.25 Thousand AUD | 73.54% |
| 2010 FY | 3.77 Million AUD | 89.56% |
| 2010 Q1 | 498 Thousand AUD | 0.0% |
| 2010 Q4 | 864.25 Thousand AUD | 0.0% |
| 2010 Q3 | 864.25 Thousand AUD | 0.0% |
| 2009 Q4 | 498 Thousand AUD | 0.0% |
| 2009 Q3 | 498 Thousand AUD | 0.0% |
| 2009 Q1 | 467 Thousand AUD | 0.0% |
| 2009 Q2 | 498 Thousand AUD | 6.64% |
| 2009 FY | 1.99 Million AUD | 6.64% |
| 2008 Q2 | 467 Thousand AUD | -44.96% |
| 2008 Q3 | 467 Thousand AUD | 0.0% |
| 2008 FY | 1.86 Million AUD | -44.96% |
| 2008 Q4 | 467 Thousand AUD | 0.0% |
| 2008 Q1 | 848.52 Thousand AUD | 0.0% |
| 2007 Q3 | 848.52 Thousand AUD | 0.0% |
| 2007 FY | 3.39 Million AUD | 0.0% |
| 2007 Q2 | 848.52 Thousand AUD | 0.0% |
| 2007 Q4 | 848.52 Thousand AUD | 0.0% |
| 2006 Q1 | - AUD | 0.0% |
| 2005 Q3 | - AUD | 0.0% |
| 2005 FY | - AUD | 0.0% |
| 2005 Q2 | - AUD | 0.0% |
| 2005 Q4 | - AUD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| 4DMedical Limited | 3.51 Million AUD | 182.927% |
| Adherium Limited | -640.83 Thousand AUD | -355.187% |
| Aroa Biosurgery Limited | 53.98 Million AUD | 105.403% |
| Atomo Diagnostics Limited | 1.43 Million AUD | 303.034% |
| Anteris Technologies Ltd | 2.51 Million AUD | 215.884% |
| Control Bionics Limited | 3.67 Million AUD | 179.422% |
| CardieX Limited | 10.1 Million AUD | 128.859% |
| Compumedics Limited | 26.06 Million AUD | 111.19% |
| Cochlear Limited | 1.69 Billion AUD | 100.172% |
| CleanSpace Holdings Limited | 11.35 Million AUD | 125.679% |
| Cyclopharm Limited | 4.49 Million AUD | 164.861% |
| EMVision Medical Devices Ltd | 11.21 Million AUD | 126.0% |
| Nova Eye Medical Limited | 20.19 Million AUD | 114.446% |
| HeraMED Limited | -504.09 Thousand AUD | -478.661% |
| Imricor Medical Systems, Inc. | -1.99 Million AUD | -46.37% |
| ImpediMed Limited | 9 Million AUD | 132.393% |
| InhaleRx Limited | 1.2 Million AUD | 342.266% |
| Micro-X Limited | 5.73 Million AUD | 150.845% |
| Neurotech International Limited | -5867.00 AUD | -49618.766% |
| OncoSil Medical Limited | 55.63 Thousand AUD | 5343.385% |
| PolyNovo Limited | 36.08 Million AUD | 108.084% |
| Respiri Limited | 456.91 Thousand AUD | 738.413% |
| SomnoMed Limited | 55.13 Million AUD | 105.291% |
| Universal Biosensors, Inc. | 4.28 Million AUD | 168.076% |
| Uscom Limited | 3.11 Million AUD | 193.623% |
| Visioneering Technologies, Inc. | -271.11 Thousand AUD | -975.923% |